For anti-PLA2R-negative MN or other nephrotic syndrome etiologies, clinicians will face the dilemma of performing an early high-risk biopsy or proceeding with empirical immunosuppressive therapy if anticoagulation cannot be interrupted. The gene discussed is PLA2R1; the disease is nephrotic syndrome.